US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
CA2115840A1
(en)
*
|
1991-08-27 |
1993-03-04 |
Tsung-Min Hsu |
Transdermal formulation for administering prazosin
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
DE4319096C1
(de)
*
|
1993-06-08 |
1994-09-08 |
Kuhl Herbert Prof Dr Phil Nat |
Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
|
US5762954A
(en)
*
|
1994-02-28 |
1998-06-09 |
Teijin Limited |
Isosorbide dinitrate-containing patch using a mixed adhesive
|
DE4407742C1
(de)
*
|
1994-03-08 |
1995-06-22 |
Hexal Pharma Gmbh |
Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
|
US5714162A
(en)
*
|
1994-09-16 |
1998-02-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Scopolamine patch
|
IT1278545B1
(it)
*
|
1994-10-13 |
1997-11-24 |
Fime Fab It Motor Elett |
Sistema di fissaggio per l'arresto delle palette metalliche delle ventole di aspirazione centrifughe
|
DE4443888A1
(de)
*
|
1994-12-09 |
1996-06-13 |
Bayer Ag |
Dermal applizierbare Formulierungen von Parasitiziden
|
US5605701A
(en)
*
|
1995-02-17 |
1997-02-25 |
Eli Lilly And Company |
Transdermal formulation
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
NZ309980A
(en)
*
|
1995-06-07 |
2001-06-29 |
Noven Pharma |
Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
|
US6316022B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Noven Pharmaceuticals, Inc. |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
DK0836506T4
(da)
*
|
1995-06-07 |
2012-01-30 |
Ortho Mcneil Pharm Inc |
Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5906830A
(en)
*
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5730721A
(en)
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US5725876A
(en)
*
|
1996-05-17 |
1998-03-10 |
Noven Pharmaceuticals Inc., |
Compositions and methods for using low-swell clays in nicotine containing dermal compositions
|
US5837289A
(en)
*
|
1996-07-23 |
1998-11-17 |
Grasela; John C. |
Transdermal delivery of medications using a combination of penetration enhancers
|
DE19635883A1
(de)
*
|
1996-09-04 |
1998-03-05 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
|
US6166081A
(en)
*
|
1997-10-09 |
2000-12-26 |
Kushnir; Moshe |
Methods and apparatus for treatment of Parkinson's disease
|
IL119417A
(en)
*
|
1996-10-13 |
2003-02-12 |
Moshe Kushnir |
Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease
|
US6746688B1
(en)
|
1996-10-13 |
2004-06-08 |
Neuroderm Ltd. |
Apparatus for the transdermal treatment of Parkinson's disease
|
US5879701A
(en)
*
|
1997-02-28 |
1999-03-09 |
Cygnus, Inc. |
Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
GB9714650D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Strakan Ltd |
Block copolymer
|
US6711436B1
(en)
|
1997-08-08 |
2004-03-23 |
Duke University |
Compositions, apparatus and methods for facilitating surgical procedures
|
JP2001513495A
(ja)
|
1997-08-08 |
2001-09-04 |
デューク ユニバーシティ |
外科的処置を容易にする組成物、装置および方法
|
EP1356806A1
(en)
*
|
1997-09-12 |
2003-10-29 |
Columbia Laboratories (Bermuda) Limited |
A pharmaceutical composition for treating dysmenorrhea and premature labor
|
DE69819748T2
(de)
*
|
1997-09-12 |
2004-09-30 |
Columbia Laboratories (Bermuda) Ltd. |
Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
|
US5919476A
(en)
*
|
1997-09-29 |
1999-07-06 |
Pmt Corporation |
Reinforced gel sheeting for scar treatment
|
ES2318233T3
(es)
*
|
1997-11-10 |
2009-05-01 |
Strakan International Limited |
Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona.
|
WO1999026571A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
US6210705B1
(en)
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US5900249A
(en)
*
|
1998-02-09 |
1999-05-04 |
Smith; David J. |
Multicomponent pain relief topical medication
|
DE19814257A1
(de)
|
1998-03-31 |
1999-10-07 |
Asta Medica Ag |
Brauseformulierungen
|
DE69926017T2
(de)
*
|
1998-04-27 |
2005-12-22 |
SurModics, Inc., Eden Prairie |
Bioaktive Wirkstoffe freisetzende Beschichtungen
|
US20020188037A1
(en)
*
|
1999-04-15 |
2002-12-12 |
Chudzik Stephen J. |
Method and system for providing bioactive agent release coating
|
DE19818955C2
(de)
*
|
1998-04-28 |
2000-06-29 |
Lohmann Therapie Syst Lts |
Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
|
DE19828273B4
(de)
|
1998-06-25 |
2005-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19828274C2
(de)
*
|
1998-06-25 |
2002-11-28 |
Rottapharm Bv |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19830648A1
(de)
*
|
1998-07-09 |
2000-01-13 |
Lohmann Therapie Syst Lts |
Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
|
DE19830649C2
(de)
*
|
1998-07-09 |
2003-04-10 |
Lohmann Therapie Syst Lts |
Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
|
DE19834496B4
(de)
|
1998-07-31 |
2004-02-26 |
Beiersdorf Ag |
Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
|
JP2002523144A
(ja)
*
|
1998-08-20 |
2002-07-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
包帯への噴霧および薬物送達システム
|
AU778992B2
(en)
*
|
1998-12-07 |
2004-12-23 |
Agi Therapeutics Research Limited |
Transdermal patch for delivering volatile liquid drugs
|
US20030170195A1
(en)
*
|
2000-01-10 |
2003-09-11 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for drug delivery
|
AU3470600A
(en)
*
|
1999-01-14 |
2000-08-01 |
David Houze |
Compositions and methods for drug delivery
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
US6337086B1
(en)
|
1999-02-06 |
2002-01-08 |
Dow Corning Corporation |
Pressure sensitive adhesive compositions for transdermal drug delivery devices
|
DE19908787A1
(de)
*
|
1999-03-01 |
2000-09-14 |
Labtec Gmbh |
Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
|
JP2002541094A
(ja)
*
|
1999-04-01 |
2002-12-03 |
アルザ・コーポレーション |
ポリウレタン薬物貯蔵部を含んでなる経皮薬物送達装置
|
DE19918105C1
(de)
*
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
FR2793689B1
(fr)
*
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
US6962691B1
(en)
*
|
1999-05-20 |
2005-11-08 |
U & I Pharmaceuticals Ltd. |
Topical spray compositions
|
WO2000074661A2
(en)
|
1999-06-05 |
2000-12-14 |
Noven Pharmaceuticals, Inc. |
Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
|
AU6528400A
(en)
|
1999-08-23 |
2001-03-19 |
David M. Ockert |
Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
|
US6264973B1
(en)
|
1999-08-26 |
2001-07-24 |
Fei Enterprises, Ltd. |
Apparatus and method for anesthetizing the cervical region of a female
|
WO2001026648A1
(fr)
*
|
1999-10-13 |
2001-04-19 |
Senju Pharmaceutical Co., Ltd. |
Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee
|
DE50009346D1
(de)
*
|
1999-11-29 |
2005-03-03 |
Novosis Ag |
Transdermalsystem zur Abgabe von Clonidin
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
US6582724B2
(en)
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
US6558695B2
(en)
*
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
US6562369B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
US6562370B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
US6645520B2
(en)
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
US6562368B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
WO2001064149A1
(en)
*
|
2000-02-29 |
2001-09-07 |
Jie Zhang |
Improved transdermal drug patch
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
DE10012908B4
(de)
*
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
KR100452972B1
(ko)
*
|
2000-05-16 |
2004-10-14 |
주식회사 삼양사 |
경피투여용 하이드로젤 조성물
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
GB0015617D0
(en)
*
|
2000-06-26 |
2000-08-16 |
Vectura Ltd |
Improved preparations for dermal delivery of active substances
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US6852526B2
(en)
*
|
2000-07-14 |
2005-02-08 |
Transform Pharmaceuticals, Inc. |
Transdermal assay with magnetic clamp
|
US7172859B2
(en)
*
|
2000-07-14 |
2007-02-06 |
Transform Pharmaceuticals, Inc. |
System and method for optimizing tissue barrier transfer of compounds
|
US20080182293A1
(en)
*
|
2000-07-14 |
2008-07-31 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples
|
AU7788701A
(en)
|
2000-07-14 |
2002-01-30 |
Transform Pharmaceuticals Inc |
System and method for optimizing tissue barrier transfer of compounds
|
AU2001292781A1
(en)
*
|
2000-09-19 |
2002-04-02 |
National Starch And Chemical Investment Holding Corporation |
Acryl adhesive useful in transdermal drug delivery systems
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
WO2002038139A1
(fr)
*
|
2000-11-07 |
2002-05-16 |
Hisamitsu Pharmaceutical Co., Inc. |
Preparation pharmaceutique du type a absorption percutanee
|
AU2002235155A1
(en)
*
|
2000-12-05 |
2002-06-18 |
Noven Pharmaceuticals, Inc. |
Crystallization inhibition of drugs in transdermal drug delivery systems
|
EP1216699A1
(de)
*
|
2000-12-21 |
2002-06-26 |
Schering Aktiengesellschaft |
Transdermalsystem enthaltend ein hochpotentes Gestagen
|
WO2002069942A1
(fr)
*
|
2001-03-07 |
2002-09-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Timbre adhesif
|
DE20220982U1
(de)
|
2001-03-16 |
2004-11-25 |
Alza Corp., Mountain View |
Transdermal-Pflaster zum Verabreichen von Fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
DE60220661T2
(de)
*
|
2001-03-16 |
2008-02-14 |
Alza Corp., Mountain View |
Transdermales pflaster zur verabreichung von fentanyl
|
DE10118282A1
(de)
*
|
2001-04-12 |
2002-12-05 |
Lohmann Therapie Syst Lts |
Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
CA2445086C
(en)
|
2001-05-01 |
2008-04-08 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
WO2002087642A2
(en)
|
2001-05-01 |
2002-11-07 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
CA2446060A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
ATE251901T1
(de)
*
|
2001-05-08 |
2003-11-15 |
Sanol Arznei Schwarz Gmbh |
Transdermales therapeutisches system für die erzielung hoher plasmaspiegel von rotigotin in der therapie von morbus parkinson
|
PT1406633E
(pt)
|
2001-06-18 |
2012-01-12 |
Noven Pharma |
Distribuição melhorada de fármacos em sistemas transdérmicos
|
AU2002329763B2
(en)
*
|
2001-08-17 |
2007-11-08 |
Lavipharm Laboratories Inc. |
Composition and transdermal drug delivery device
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
WO2003022270A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of an enalapril ester
|
US6805878B2
(en)
|
2001-09-13 |
2004-10-19 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of ACE inhibitors
|
US8425892B2
(en)
|
2001-10-29 |
2013-04-23 |
Columbia Laboratories, Inc. |
Extended, controlled-release pharmaceutical compositions using charged polymers
|
US20030147972A1
(en)
*
|
2002-02-05 |
2003-08-07 |
Christopher W. Denver |
Method and composition for diminishing loss of color in flavors and fragrances
|
JP2005519964A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファターゼ阻害プロゲストゲンのみの避妊レジメン
|
US20030219471A1
(en)
*
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
ATE336252T1
(de)
*
|
2002-03-11 |
2006-09-15 |
Janssen Pharmaceutica Nv |
Kontinuierliche sulfatase-hemmende progestogen enthaltende hormonsubstitutions-therapie
|
JP2005526839A
(ja)
*
|
2002-04-23 |
2005-09-08 |
アルザ・コーポレーシヨン |
不正使用の可能性が低い経皮鎮痛薬システム
|
DE10220230A1
(de)
*
|
2002-05-06 |
2003-11-27 |
Sanol Arznei Schwarz Gmbh |
Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
DE10223835A1
(de)
*
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
AU2003243896B2
(en)
*
|
2002-05-28 |
2008-07-03 |
Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh |
Plaster containing fentanyl
|
US20030232087A1
(en)
*
|
2002-06-18 |
2003-12-18 |
Lawin Laurie R. |
Bioactive agent release coating with aromatic poly(meth)acrylates
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
EP1560589B1
(en)
*
|
2002-06-20 |
2006-10-04 |
Astion Dermatology A/S |
Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide
|
EA009024B1
(ru)
|
2002-06-25 |
2007-10-26 |
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи |
Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
|
JP2006500088A
(ja)
*
|
2002-08-13 |
2006-01-05 |
メドトロニック・インコーポレーテッド |
ポリマーの被覆及び支持体間の改良された付着を示す医用デバイス
|
AU2003265446A1
(en)
*
|
2002-08-13 |
2004-02-25 |
Medtronic, Inc. |
Active agent delivery system including a hydrophilic polymer, medical device, and method
|
CA2495172A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
EP1536846A1
(en)
*
|
2002-08-13 |
2005-06-08 |
Medtronic, Inc. |
Active agent delivery system including a polyurethane, medical device, and method
|
DE60326354D1
(de)
*
|
2002-08-20 |
2009-04-09 |
Euro Celtique Sa |
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
|
WO2004098472A1
(en)
*
|
2002-08-30 |
2004-11-18 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
EP1539284B1
(en)
*
|
2002-09-06 |
2020-01-29 |
Philip Morris Products S.a.s. |
Aerosol generating device and method for generating aerosols
|
US7241456B2
(en)
*
|
2002-10-25 |
2007-07-10 |
Australian Importers Ltd. |
Formulations for topical delivery of bioactive substances and methods for their use
|
US7449307B2
(en)
*
|
2002-10-28 |
2008-11-11 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US6908760B2
(en)
*
|
2002-10-28 |
2005-06-21 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
SI1575569T1
(sl)
|
2002-12-13 |
2010-12-31 |
Durect Corp |
Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
|
US20040147534A1
(en)
*
|
2003-01-23 |
2004-07-29 |
Foote Mary Ann |
Topical composition and method for treating occlusive wounds
|
JP4363866B2
(ja)
*
|
2003-03-14 |
2009-11-11 |
リンテック株式会社 |
皮膚貼付材用シリコーン粘着剤組成物及びこれを用いた皮膚貼付材
|
GB0308734D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20040208917A1
(en)
*
|
2003-04-16 |
2004-10-21 |
Wilfried Fischer |
Transdermal systems for the release of clonidine
|
JP4898431B2
(ja)
*
|
2003-04-29 |
2012-03-14 |
ザ ジェネラル ホスピタル コーポレイション |
複数薬物の持続放出のための方法およびデバイス
|
MY141815A
(en)
|
2003-04-30 |
2010-06-30 |
Purdue Pharma Lp |
Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
|
US7182955B2
(en)
*
|
2003-04-30 |
2007-02-27 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
US20040219195A1
(en)
*
|
2003-04-30 |
2004-11-04 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US20040237400A1
(en)
*
|
2003-05-27 |
2004-12-02 |
Weder Donald E. |
Plant package with floral wrapper with decorative portion
|
US7816546B2
(en)
*
|
2003-06-30 |
2010-10-19 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
|
US20050019385A1
(en)
*
|
2003-07-21 |
2005-01-27 |
Noven Pharmaceuticals, Inc. |
Composition and method for controlling drug delivery from silicone adhesive blends
|
EP1684820A2
(en)
*
|
2003-08-13 |
2006-08-02 |
Medtronic, Inc. |
Active agent delivery systems including a miscible polymer blend, medical devices, and methods
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
EP1682102A2
(en)
*
|
2003-09-10 |
2006-07-26 |
Noven Pharmaceuticals, Inc. |
Multi-layer transdermal drug delivery device
|
US8586080B1
(en)
*
|
2003-10-28 |
2013-11-19 |
Noven Pharmaceuticals, Inc. |
Inhibiting crystallization of steroidal hormones in transdermal delivery systems
|
GEP20084561B
(en)
*
|
2003-10-28 |
2008-12-10 |
Noven Pharma |
System and method for controlled drug release and transdermal drug delivery device
|
JP2007527415A
(ja)
|
2003-10-30 |
2007-09-27 |
アルザ・コーポレーシヨン |
乱用の可能性が低い経皮鎮痛剤システム
|
RU2380092C2
(ru)
|
2004-01-30 |
2010-01-27 |
Кориум Интернэшнл, Инк. |
Быстро растворяющаяся пленка для доставки активного агента
|
AU2011203203B2
(en)
*
|
2004-03-09 |
2014-04-10 |
Mylan Technologies, Inc |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US9205062B2
(en)
*
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050202073A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050244459A1
(en)
|
2004-04-06 |
2005-11-03 |
Dewitt David M |
Coating compositions for bioactive agents
|
US20060083772A1
(en)
*
|
2004-04-06 |
2006-04-20 |
Dewitt David M |
Coating compositions for bioactive agents
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
EP1791575B1
(en)
|
2004-08-05 |
2014-10-08 |
Corium International, Inc. |
Adhesive composition
|
WO2006023644A2
(en)
*
|
2004-08-20 |
2006-03-02 |
3M Innovative Properties Company |
Transdermal drug delivery device with translucent protective film
|
WO2006041908A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
US20060078602A1
(en)
|
2004-10-08 |
2006-04-13 |
Noven Pharmaceuticals, Inc. |
Device for transdermal administration of drugs including acrylic polymers
|
EP1807033B1
(en)
*
|
2004-10-08 |
2016-07-20 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
WO2006041907A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
EP1814531B1
(en)
|
2004-10-21 |
2010-06-16 |
Durect Corporation |
Transdermal delivery systems
|
WO2006063021A2
(en)
*
|
2004-12-07 |
2006-06-15 |
Surmodics, Inc. |
Coatngs with crystallized active agents (s)
|
KR100810947B1
(ko)
|
2005-01-28 |
2008-03-10 |
롬 앤드 하아스 컴패니 |
에멀젼 폴리머로부터 제조된 의료용 필름 및 제품
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
ITMI20050477A1
(it)
*
|
2005-03-23 |
2006-09-24 |
Bouty S P A |
Cerotto transdermico
|
GB0506139D0
(en)
*
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
US20060281775A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Applied Pharmacy Services, Inc. |
Two-component pharmaceutical composition for the treatment of pain
|
WO2007035940A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal norelgestromin delivery system
|
WO2007035939A2
(en)
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
WO2007035941A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal galantamine delivery system
|
US20090130188A9
(en)
|
2005-09-29 |
2009-05-21 |
National Starch And Chemical Investment Holding Company |
Acrylic pressure sensitive adhesives
|
ES2499067T3
(es)
|
2005-10-13 |
2014-09-26 |
Nitto Denko Corporation |
Preparación transdérmica de nicotina y método de producción de la misma
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
EP1940368A2
(en)
*
|
2005-10-25 |
2008-07-09 |
Dow Corning Corporation |
Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition
|
KR20070059758A
(ko)
*
|
2005-12-07 |
2007-06-12 |
에스케이케미칼주식회사 |
비스테로이드성 항염증제와 국소마취제를 포함하는 경피투여 조성물
|
US9393218B2
(en)
*
|
2005-12-23 |
2016-07-19 |
Epinamics Gmbh |
Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
|
EP1988107B1
(en)
*
|
2006-02-23 |
2011-04-20 |
Mitsubishi Rayon Co. Ltd. |
(meth)acrylic polymer particle, method for producing the same, plastisol, and article
|
EP1998756A2
(en)
*
|
2006-02-27 |
2008-12-10 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
US20070225425A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Nash Paul L |
Low tack elastomer composition, part and methods
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
US8614278B2
(en)
|
2006-06-06 |
2013-12-24 |
Dow Corning Corporation |
Silicone acrylate hybrid composition and method of making same
|
EP2024406B1
(en)
*
|
2006-06-06 |
2012-08-01 |
Dow Corning Corporation |
A silicone acrylate hybrid composition
|
US8569416B2
(en)
|
2006-06-06 |
2013-10-29 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
CA2657435A1
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
US8647664B2
(en)
|
2006-07-14 |
2014-02-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive preparation
|
MX2009004358A
(es)
*
|
2006-10-27 |
2009-06-17 |
Noven Pharma |
Suministro transdermico de derivados polares de cetoprofeno.
|
DK2117521T3
(da)
|
2006-11-03 |
2012-09-03 |
Durect Corp |
Transdermale indgivelsessystemer omfattende bupivacain
|
DE102006054732B4
(de)
*
|
2006-11-21 |
2010-12-30 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
|
CA2674681C
(en)
*
|
2007-01-11 |
2014-12-02 |
Drossapharm Ag |
Medically active plaster for releasing an active compound that is liquid at room temperature
|
US8039541B2
(en)
*
|
2007-01-23 |
2011-10-18 |
Mitsubishi Rayon Co., Ltd. |
(Meth)acrylic polymer particle, method for producing the same, plastisol composition made from the polymer particle, and article made from the plastisol composition
|
US20080188446A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Warner Chilcott Company Inc. |
Tetracycline compositions for topical administration
|
CN101147739B
(zh)
*
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
US8246978B2
(en)
*
|
2007-07-10 |
2012-08-21 |
Agile Therapeutics, Inc. |
Dermal delivery device with reduced loss of its volatile components
|
WO2009026178A2
(en)
*
|
2007-08-17 |
2009-02-26 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
CN101902996B
(zh)
|
2007-10-15 |
2014-11-26 |
阿尔扎公司 |
芬太尼的一天更换一次透皮施用
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
WO2009073734A2
(en)
*
|
2007-12-03 |
2009-06-11 |
Medipacs, Inc. |
Fluid metering device
|
CA2706931C
(en)
|
2007-12-06 |
2015-05-12 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US9700552B2
(en)
*
|
2008-02-28 |
2017-07-11 |
Syntropharma Limited |
Pharmaceutical compositions for treatment of addiction
|
US8231906B2
(en)
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
CN102137908B
(zh)
*
|
2008-07-28 |
2013-10-30 |
陶氏康宁公司 |
复合制品
|
WO2010019953A1
(en)
|
2008-08-15 |
2010-02-18 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations for treating non-neuropathic pain
|
RU2497679C2
(ru)
|
2008-10-02 |
2013-11-10 |
Милан Инк. |
Способ получения многослойного клеящегося ламинированного материала
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US8784879B2
(en)
|
2009-01-14 |
2014-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
WO2010109544A1
(ja)
*
|
2009-03-27 |
2010-09-30 |
株式会社メドレックス |
核酸を有効成分とする外用剤組成物
|
KR101452788B1
(ko)
|
2009-04-24 |
2014-10-21 |
헨켈 유에스 아이피 엘엘씨 |
실리콘 아크릴 혼성 중합체-기재 접착제
|
US8299079B2
(en)
*
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US8658628B2
(en)
*
|
2009-06-18 |
2014-02-25 |
Karan Y. Baucom |
Hormone delivery system and method
|
US9795617B2
(en)
|
2009-06-18 |
2017-10-24 |
Baucom Institute for Longevity and Life Enhancement, Inc. |
Hormone delivery system and method
|
US20110037455A1
(en)
*
|
2009-08-17 |
2011-02-17 |
Oren Navot |
System for measuring electrical power
|
CH701769A1
(de)
|
2009-09-08 |
2011-03-15 |
Schoeller Textil Ag |
Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen.
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
US9320742B2
(en)
*
|
2009-12-01 |
2016-04-26 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
CA2796575C
(en)
|
2010-04-13 |
2018-05-15 |
Relmada Therapeutics, Inc. |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
CN102947370B
(zh)
|
2010-04-23 |
2016-05-11 |
汉高知识产权控股有限责任公司 |
硅酮-丙烯酸共聚物
|
EP2601245A1
(en)
|
2010-08-05 |
2013-06-12 |
Biofilm IP, LLC |
Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
US20120123369A1
(en)
*
|
2010-11-12 |
2012-05-17 |
David Harry Melik |
Elastomeric compositions that resist force loss and disintegration
|
US9017305B2
(en)
|
2010-11-12 |
2015-04-28 |
The Procter Gamble Company |
Elastomeric compositions that resist force loss and disintegration
|
US11241391B2
(en)
|
2011-03-23 |
2022-02-08 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US10905652B2
(en)
|
2011-03-23 |
2021-02-02 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US8916588B2
(en)
|
2011-03-23 |
2014-12-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods for treatment of attention deficit hyperactivity disorder
|
US9283214B2
(en)
|
2011-03-23 |
2016-03-15 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9498447B2
(en)
|
2011-03-23 |
2016-11-22 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9603809B2
(en)
|
2011-03-23 |
2017-03-28 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
EP4011364B1
(en)
|
2011-03-23 |
2023-12-13 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods and compositions for treatment of attention deficit disorder
|
US10292937B2
(en)
|
2011-03-23 |
2019-05-21 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
US9119809B2
(en)
|
2011-03-23 |
2015-09-01 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
DE102011114411A1
(de)
|
2011-09-26 |
2013-03-28 |
Lts Lohmann Therapie-Systeme Ag |
Pflaster mit einstellbarer Okklusion
|
EP2584016A1
(en)
|
2011-10-21 |
2013-04-24 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
BR112014012444B1
(pt)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd, Inc |
Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
JP2013139554A
(ja)
|
2011-11-29 |
2013-07-18 |
Dow Corning Corp |
シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
|
EP2847249A4
(en)
|
2012-03-14 |
2016-12-28 |
Medipacs Inc |
SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US9717697B2
(en)
|
2012-10-15 |
2017-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for the transdermal delivery of methylphenidate
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
AR094289A1
(es)
|
2012-12-28 |
2015-07-22 |
Noven Pharma |
Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
|
TW201438767A
(zh)
*
|
2012-12-28 |
2014-10-16 |
Noven Pharma |
用於經皮傳遞非類固醇抗發炎劑之組合物及方法
|
ES2864327T3
(es)
|
2012-12-28 |
2021-10-13 |
Noven Pharma |
Composiciones de múltiples polímeros para la administración transdérmica de fármacos
|
AU2013371582B2
(en)
|
2013-01-02 |
2018-01-18 |
3M Innovative Properties Company |
A medical drape having an ultra-thin drape film and a thick adhesive coating
|
US20160008282A1
(en)
|
2013-02-22 |
2016-01-14 |
The Board Of Trustees Of The Universityof Illinois |
Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
EP2983468A4
(en)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
CA2916183C
(en)
|
2013-07-03 |
2022-03-29 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system with electronic component
|
JP6515803B2
(ja)
*
|
2014-05-12 |
2019-05-22 |
三菱ケミカル株式会社 |
アクリル系重合体、その製造方法及びそのアクリル系重合体を含むプラスチゾル組成物
|
CA2948221C
(en)
|
2014-05-20 |
2022-11-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system including an interface mediator
|
WO2015177204A1
(en)
|
2014-05-20 |
2015-11-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system containing rotigotine
|
EP3145503A1
(en)
|
2014-05-20 |
2017-03-29 |
LTS Lohmann Therapie-Systeme AG |
Method for adjusting the release of active agent in a transdermal delivery system
|
JP5816881B2
(ja)
*
|
2014-05-21 |
2015-11-18 |
株式会社 メドレックス |
核酸を有効成分とする外用剤組成物
|
JP2017516768A
(ja)
|
2014-05-22 |
2017-06-22 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
天然の併用ホルモン補充療法剤及び療法
|
US20170112126A1
(en)
|
2014-06-10 |
2017-04-27 |
Sabic Global Technologies B.V. |
Insecticide-containing coating composition and method for protecting palm trees from pests
|
ES2784756T3
(es)
|
2014-07-18 |
2020-09-30 |
Buzzz Pharmaceuticals Ltd |
Parche transdérmico opioide/antagonista de opioides disuasivo del abuso
|
MX2016013693A
(es)
|
2014-07-29 |
2017-10-31 |
Therapeuticsmd Inc |
Crema transdermica.
|
TWI682790B
(zh)
|
2014-07-31 |
2020-01-21 |
美商諾芬藥品公司 |
用於經皮藥物遞送組合物之含聚矽氧之丙烯酸聚合物
|
WO2016042413A1
(en)
|
2014-09-18 |
2016-03-24 |
Neuroderm, Ltd. |
Opipramol patch
|
US10010543B1
(en)
|
2014-12-23 |
2018-07-03 |
Barr Laboratories, Inc. |
Transdermal dosage form
|
JP2018511661A
(ja)
|
2015-01-29 |
2018-04-26 |
ダウ コーニング コーポレーションDow Corning Corporation |
シリコーンアクリレート組成物及びその調製方法
|
CN107532050B
(zh)
|
2015-02-06 |
2021-03-02 |
诺芬药品公司 |
用于透皮给药的压敏粘合剂
|
US10406116B2
(en)
|
2015-02-06 |
2019-09-10 |
Noven Pharmaceuticals, Inc. |
Pressure-sensitive adhesives for transdermal drug delivery
|
US20160256406A1
(en)
*
|
2015-03-04 |
2016-09-08 |
Noven Pharmaceuticals, Inc. |
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems
|
JP6526475B2
(ja)
*
|
2015-04-30 |
2019-06-05 |
サンスター株式会社 |
経皮唾液腺投与用の唾液分泌促進剤
|
US20180125860A1
(en)
*
|
2015-05-18 |
2018-05-10 |
Agile Therapeutics, Inc. |
Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
JP6304457B2
(ja)
*
|
2015-08-27 |
2018-04-04 |
東洋インキScホールディングス株式会社 |
貼付剤
|
WO2017048595A1
(en)
*
|
2015-09-14 |
2017-03-23 |
Amneal Pharmaceuticals Llc |
Transdermal delivery system
|
US20210100754A1
(en)
|
2016-02-05 |
2021-04-08 |
3M Innovative Properties Company |
Transdermal drug delivery systems with fluorosilicone release liners
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
EP3435977A4
(en)
|
2016-04-01 |
2019-10-16 |
Therapeuticsmd, Inc. |
PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
|
EP3474831A1
(en)
*
|
2016-06-23 |
2019-05-01 |
Corium International, Inc. |
Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
|
CN115813888A
(zh)
|
2016-12-20 |
2023-03-21 |
罗曼治疗系统股份公司 |
包含阿塞那平的透皮治疗系统
|
EP3558276A1
(en)
|
2016-12-20 |
2019-10-30 |
LTS Lohmann Therapie-Systeme AG |
Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
|
JP2020525545A
(ja)
|
2017-06-26 |
2020-08-27 |
エルテーエス ローマン テラピー−ジステーメ アーゲー |
アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
|
WO2019186300A1
(en)
|
2018-03-28 |
2019-10-03 |
Sabic Global Technologies B.V. |
Peelable adhesive protective film to protect palm trees from the attack of red palm weevil pest
|
EP3775086B1
(en)
|
2018-04-05 |
2022-09-14 |
3M Innovative Properties Company |
Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
|
MX2020014286A
(es)
|
2018-06-20 |
2021-03-25 |
Lts Lohmann Therapie Systeme Ag |
Sistema terapeutico transdermico que contiene asenapina.
|
WO2020008370A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal patch
|
WO2020009685A1
(en)
|
2018-07-02 |
2020-01-09 |
John Tang |
Transdermal dosage form
|
WO2020008366A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal dosage form
|
JP7227144B2
(ja)
*
|
2018-07-12 |
2023-02-21 |
積水化学工業株式会社 |
粘着剤組成物及び貼付剤
|
CN112206222A
(zh)
*
|
2018-11-09 |
2021-01-12 |
北京德默高科医药技术有限公司 |
含有布洛芬结构类似物的多层经皮给药系统
|
JP6912122B2
(ja)
*
|
2019-02-28 |
2021-07-28 |
日本臓器製薬株式会社 |
経皮投与製剤
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|